Blue Ash Therapeutics, LLC
http://blueashtx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Blue Ash Therapeutics, LLC
Forest As An Aggressive In-Licenser
A steady stream of dealmaking in recent years, primarily small, in-licensing transactions to build pipeline and portfolio, transformed Forest under the leadership of longtime CEO Howard Solomon. The activity was driven in large part by the anticipated, huge 2012 patent cliff, but it was far from enough.
Forest As An Aggressive In-Licensor
A steady stream of deal-making in recent years, primarily small, in-licensing transactions to build pipeline and portfolio, transformed Forest under the leadership of longtime CEO Howard Solomon. The activity was driven in large part by the anticipated, huge 2012 patent cliff, but it was far from enough.
Deals Shaping the Medical Industry (06/2011)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.
Small Bone Innovations LLC
The founders of Small Bone Innovations believes the device industry is entering the decade of small bones and joints, and has embarked on a consolidation strategy to prepare for dramatic innovation and change in what today is a fragmented marketplace.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice